SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-005333
Filing Date
2021-01-19
Accepted
2021-01-19 16:16:36
Documents
3
Period of Report
2021-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213532d1_8k.htm 8-K 47948
2 EXHIBIT 3.1 tm213532d1_ex3-1.htm EX-3.1 26280
3 EXHIBIT 4.1 tm213532d1_ex4-1.htm EX-4.1 278759
  Complete submission text file 0001104659-21-005333.txt   354372
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-249434 | Film No.: 21535692
SIC: 2834 Pharmaceutical Preparations